Track biopharma regulatory updates with feeds – Feedly Blog

Clinical trial updates produce overwhelming quantities of data every single day. But a small portion of those articles refers back to the ailments and research you need to monitor.

Cut by way of the noise and construct customized RSS feeds on with the knowledge you want.

Go to

You are the top of an AIDS analysis program in a big pharma firm. You can create a question on to look into scientific trial information coming from different analysis labs.

Go to

Create your question covers a variety of scientific trials that happen every single day. You can both search a single key phrase or create a complicated question with sure examine sorts, areas, ages…

Select the illness you need to observe

You can discover extra details about tips on how to use the search.

Subscribe to your customized RSS feed

You can look into the outcomes of your question and add further filters if wanted. When you’re happy with the entries, click on ‘Subscribe to RSS’.

This will lead you to the RSS feed you’ll have to repeat.

Click ‘Subscribe to RSS’ on the highest right-hand nook
We advocate choosing ‘Show studies added or modified in the last 14 days’. 
Copy the RSS hyperlink from this tab

Add your customized RSS feed to your Feedly

Click ‘+’ on Feedly to stick the RSS feed you simply copied. Add it to any of the feeds you’d like and begin studying your chosen content material!

Paste your RSS feed into your Feedly
Read, annotate and save the articles to your boards

Streamline your biopharma intelligence

We’re excited to see how your group will declutter your feeds and dig deeper into the biopharma information that matter to you. Sign up as we speak and uncover Feedly for Biopharma.

If you’re inquisitive about studying extra in regards to the Feedly for Biopharma roadmap, you possibly can demo a name by clicking on the button above. 2020 will probably be an exciting yr with new abilities and daring experiments!

Be the first to comment

Leave a Reply

Your email address will not be published.